<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's Disease</z:e> (BD) is classified as a <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, and progresses via attacks and remissions </plain></SENT>
<SENT sid="1" pm="."><plain>BD is mainly seen around the Silk Road </plain></SENT>
<SENT sid="2" pm="."><plain>The picture varies in different reports </plain></SENT>
<SENT sid="3" pm="."><plain>For clinical descriptions, the data from the international cohort of patients (27 countries), will be used </plain></SENT>
<SENT sid="4" pm="."><plain>CLINICAL MANIFESTATIONS: Mucous membrane manifestations were oral <z:e sem="disease" ids="C0016514" disease_type="Disease or Syndrome" abbrv="">aphthosis</z:e> seen in 98.1%, and genital <z:e sem="disease" ids="C0016514" disease_type="Disease or Syndrome" abbrv="">aphthosis</z:e> in 76.9% of patients </plain></SENT>
<SENT sid="5" pm="."><plain>Skin manifestations were seen in 71.9% (<z:e sem="disease" ids="C0406191" disease_type="Disease or Syndrome" abbrv="">pseudofolliculitis</z:e> in 53.6% and <z:hpo ids='HP_0010783'>erythema</z:hpo> nodosum in 33.6%) </plain></SENT>
<SENT sid="6" pm="."><plain>Ocular manifestations were seen in 53.7% (<z:hpo ids='HP_0012122'>anterior uveitis</z:hpo> 38.8%, <z:hpo ids='HP_0012123'>posterior uveitis</z:hpo> 36.9%, <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:hpo ids='HP_0002633'>vasculitis</z:hpo> 23.5%) </plain></SENT>
<SENT sid="7" pm="."><plain>Joint manifestations were seen in 50.5% (<z:hpo ids='HP_0002829'>arthralgia</z:hpo>, <z:e sem="disease" ids="C0158026,C0494905" disease_type="Disease or Syndrome" abbrv="">monoarthritis</z:e>, oligo/<z:e sem="disease" ids="C0162323" disease_type="Disease or Syndrome" abbrv="">polyarthritis</z:e>, <z:e sem="disease" ids="C0038013" disease_type="Disease or Syndrome" abbrv="">ankylosing spondylitis</z:e>) </plain></SENT>
<SENT sid="8" pm="."><plain>Neurological manifestations were seen in 15.5% of patients (central 11.5%, peripheral 4.4%) </plain></SENT>
<SENT sid="9" pm="."><plain>Gastrointestinal manifestations were seen in 6.3% of patients </plain></SENT>
<SENT sid="10" pm="."><plain>Vascular involvement was seen in 18.2% of patients and arterial involvement in 3% (<z:mp ids='MP_0005048'>thrombosis</z:mp>, <z:hpo ids='HP_0002617'>aneurysm</z:hpo>, pulse <z:mp ids='MP_0000746'>weakness</z:mp>) </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0002625'>Deep vein thrombosis</z:hpo> was seen in 8%, large vein <z:mp ids='MP_0005048'>thrombosis</z:mp> in 6.5%, and superficial <z:mp ids='MP_0010140'>phlebitis</z:mp> in 5.8% </plain></SENT>
<SENT sid="12" pm="."><plain><z:hpo ids='HP_0100796'>Orchitis</z:hpo> and <z:hpo ids='HP_0000031'>epididymitis</z:hpo> were seen in 7.2% </plain></SENT>
<SENT sid="13" pm="."><plain><z:e sem="disease" ids="C0878631" disease_type="Disease or Syndrome" abbrv="">Pathergy</z:e> test was positive in 49.3% and HLA-B51 in 49.1% of patients </plain></SENT>
<SENT sid="14" pm="."><plain>DIAGNOSIS: Diagnosis is based on clinical manifestations </plain></SENT>
<SENT sid="15" pm="."><plain>The International Criteria for <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's Disease</z:e> (ICBD) may be helpful </plain></SENT>
<SENT sid="16" pm="."><plain>TREATMENT: The first line treatment is <z:chebi fb="0" ids="23359">colchicine</z:chebi> (1 mg daily) for mucocutaneous manifestations, <z:chebi fb="2" ids="35475">non-steroidal anti-inflammatory drugs</z:chebi> for joint manifestations, anticoagulation for vascular <z:mp ids='MP_0005048'>thrombosis</z:mp>, and cytotoxic drugs for ocular and brain manifestations </plain></SENT>
<SENT sid="17" pm="."><plain>If incomplete response or resistance occurs, therapeutic escalation is worthwhile </plain></SENT>
<SENT sid="18" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> is a <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic disease</z:e> characterized by mucocutaneous, ocular, vascular and neurologic manifestations, progressing by attacks and remissions </plain></SENT>
</text></document>